Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy.
OBJECTIVE
To determine the cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate (DMPA) therapy.


METHODS
Sixty-one patients with symptomatic endometriosis, who had been treated with DMPA for 15 months and were satisfied with the treatment, were included in the present study. Telephone questionnaires were used to collect information including pain recurrence. Medical records were reviewed to obtain more information. Estimates of cumulative recurrence rates of pain were calculated using the Kaplan-Meier technique and estimates of risk were computed using the Cox proportional hazards models.


RESULTS
The cumulative recurrence rates of pain after DMPA treatment were 18%, 28%, 41%, 46%, and 50% at months 12, 24, 36, 48, and 60, respectively. Age > 30 years (hazard ratio = 4.40 [95% CI, 1.45-13.37]; p = 0.009), moderate to severe stages of endometriosis (3.02 [1.30-7.03]; p = 0.010), and severe pain prior to treatment (7.80 [1.02-59.61]; p = 0.048) were found to be independent risk factors for the recurrence of pain.


CONCLUSIONS
Half of the patients had recurrent pain five years after DMPA treatment ended.
Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. csophon@medicine.psu.ac.th
Sopon
S
Cheewadhanaraks
D000328:Adult; D003692:Delayed-Action Preparations; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D012008:Recurrence
D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate